About this trial
This research will study natural course of dry AMD in Chinese population, screen fundus imaging indicators for patients with Chinese dry AMD, describe the clinical features of Chinese patients with dry AMD, and obtain a biological sample library of dry AMD mainly in China.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
50-85 yrs male or female AMD patients
Dry-AMD patients in either early, intermediate, or intermediate-to-late stage confirmed by fundus examinations.
Disqualifiers
Any eye with disease that would interfere with the retinal examinations
Research eye with CNV or high myopia
Surgeries that may interfere with AMD evaluation
Long-term uses of medications that are associated with retinal or neural toxicities.
Trial population
Dry AMD patients in Shanghai General Hospital
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Visual acuity
A typical ETDRS chart that if frequently used for visual acuity testing
Secondary outcomes
Drusen density and shape
Drusen Measurement on OCT or Fundus photography
The rate of 5-year progression
The evaluation criteria for progression: progress to intermediate (only for patients with early phase AMD at baseline) or intermediate-to-late, or late stage AMD.
GA growth rate
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: